On March 30, 2023, Guangdong Bogong Medical Technology Co., Ltd. (Bogong Technology) and Guangdong Jinzhuan Biotechnology Co., Ltd. (Jinzhuan Biology) reached a strategic cooperation. The two parties will deepen the application of life science robots in stem cell laboratory scenarios, promote the intelligent development of future laboratories, and help the technology and R&D innovation of the life science industry.
n line with the concept of "oriented to user needs, oriented to cost structure, and oriented to commercial delivery", this strategic cooperation is a milestone for both parties. The related applications of laboratory automation and informatization will provide users in industries such as life sciences, gene sequencing, clinical diagnosis, biomedicine, cell and molecular biology, drug screening, chemical engineering, medical and health inspection and quarantine, education and scientific research with full-process solutions. Automation, intelligence and digital solutions.
At the signing ceremony, the two parties stated that they would take this opportunity to join forces to give full play to their respective advantages in the field of stem cell artificial intelligence laboratories, jointly promote the application of life science robots in the field of stem cell laboratories, and use biomedical laboratories to automate gene cells. The domestic substitution upgrade and commercialization process of drugs.金專生物總經(jīng)理陳風(fēng)輝表示："I am very pleased to have reached a strategic cooperation with Bogong Technology, the leader of domestic first-class stem cell cultivation robots. I believe that Bogong's excellent team and advanced core equipment can promote technological innovation and upgrading, and product application transformation, so as to accelerate the development of Jinzhuan biological cells and genes. The process of commercialization, automation and intelligence in treatment.”
Jinzhuan Bio AI Artificial Intelligence Laboratory
Wang Zhengyuan, deputy general manager of Bogong Technology, said: "Thank you very much for the trust and choice of the Jinzhuan Biotech team. The uniqueness and innovation of immune cell products, and the R&D team's spirit of continuous improvement in production technology, this strong alliance with Jinzhuan Biotechnology's stem cell artificial intelligence laboratory will definitely promote the industrialization and commercialization of gene cell drugs in China The process of globalization will promote more products to market faster and serve more people."
About Jinpao
Jinzhuan Biotechnology Co., Ltd. is a professional company engaged in life science research and industrialization. It is an innovative high-tech biotechnology enterprise driven by cells and genes. The company has rich experience in scientific research and clinical practice, as well as a world-leading scientific research and technical team.
Over the years, the Jinzhuan biological research team has been focusing on the research and development, application and promotion of stem cell technology and immune cell technology, and is determined to create a "trinity" industrial chain pattern integrating stem cell industry base, adult stem cell bank, and high-end regenerative medicine anti-aging center . Help the progress of China's biological cell industry, effectively promote the transformation of life science and technology achievements, realize the vision of life science and technology benefiting society, and rapidly promote the research and development and clinical application of cell and gene therapy products.
About Bogong Technology
Bogong Technology is a scientific research enterprise engaged in the research and development, production and sales of life science laboratory robots. It has top scientists and is committed to providing professional robot products and solutions for users in biomedicine and life science laboratory scenarios. The self-developed life science laboratory robot products and digital laboratory management system have obtained a number of national invention patents, and the core technology has an international leading edge.
Adhering to the mission of "making artificial intelligence achieve the beauty of medicine", the company is deeply involved in the field of life sciences and biomedical laboratory automation subdivisions. With a large number of successful application cases of intelligent equipment in stem cell industry laboratories, it is the leader of stem cell cultivation robots.
